227 related articles for article (PubMed ID: 24186700)
41. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
42. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
43. Salmeterol/fluticasone propionate: a review of its use in asthma.
McKeage K; Keam SJ
Drugs; 2009; 69(13):1799-828. PubMed ID: 19719334
[TBL] [Abstract][Full Text] [Related]
44. Adherence and usage patterns of inhaled corticosteroids-long-acting beta-agonists by using inhaler-monitoring technology.
Stanford RH; Averell CM; Johnson PT; Buysman EK; Carlyle MH
Allergy Asthma Proc; 2020 Jul; 41(4):256-264. PubMed ID: 32605696
[No Abstract] [Full Text] [Related]
45. Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study.
Sicras-Mainar A; Gómez Rodríguez B; Traseira-Lugilde S; Fernández-Sánchez T; Velasco Garrido JL
BMJ Open; 2022 Apr; 12(4):e053964. PubMed ID: 35443946
[TBL] [Abstract][Full Text] [Related]
46. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
[TBL] [Abstract][Full Text] [Related]
47. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
48. Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma.
Miller E; Sears MR; McIvor A; Liovas A
Can Respir J; 2007; 14(5):269-75. PubMed ID: 17703241
[TBL] [Abstract][Full Text] [Related]
49. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
50. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
51. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
52. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
53. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment.
Brüggenjürgen B; Ezzat N; Kardos P; Buhl R
Allergy; 2010 Sep; 65(9):1108-15. PubMed ID: 20121768
[TBL] [Abstract][Full Text] [Related]
54. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
55. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
56. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
Hagiwara M; Delea TE; Stanford RH; Stempel DA
Allergy Asthma Proc; 2010; 31(3):203-10. PubMed ID: 20534183
[TBL] [Abstract][Full Text] [Related]
57. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
[TBL] [Abstract][Full Text] [Related]
58. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
59. Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
Schmidt O; Petro W; Hoheisel G; Kanniess F; Oepen P; Langer-Brauburger B
Respir Med; 2017 Oct; 131():166-174. PubMed ID: 28947024
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
Korn S; Buhl R
Respir Med; 2012 Jan; 106(1):57-67. PubMed ID: 21890335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
